COVID-19 research campaign moves from basic science to antiviral drug design (IMAGE)

DOE/Oak Ridge National Laboratory

COVID-19 research campaign moves from basic science to antiviral drug design

Caption

ORNL researchers have developed hybrid molecules in an effort to design new drugs to treat COVID-19. The experimental molecules combine components from drugs used to treat hepatitis C (boceprevir) and the original coronavirus outbreak (GC-376). Here, the BBH-1 hybrid molecule binds to the SARS-CoV-2 enzyme to block the virus’s ability to reproduce.

Credit

ORNL/Jill Hemman

Usage Restrictions

No restrictions.

License

Public Domain

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.